Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Krone

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMC Neurology|July 20, 2013
Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?Bernd Krone, John M Grange
Inflammopharmacology|May 7, 2011
Paradigms in multiple sclerosis: time for a change, time for a unifying conceptBernd Krone, John M Grange
Autoimmune Diseases|January 4, 2011
Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background?Bernd Krone, John M Grange
Journal of Neurology|March 3, 2009
Is the risk of multiple sclerosis related to the 'biography' of the immune system?Bernd Krone, Frank Oeffner, John M Grange
European Journal of Cancer (Oxford, England : 1990)|June 6, 2009
Immunotherapy for malignant melanoma--tracing Ariadne's thread through the labyrinthJohn M Grange, Bernd Krone, John L Stanford
BMC Cancer|August 17, 2014
The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategiesBernd Krone, Klaus F Kölmel, John M Grange
Scandinavian Journal of Infectious Diseases|January 16, 2004
Impact of conventional chemotherapy on levels of antibodies against vaccine-preventable diseases in children treated for cancerDirk Reinhardt, Katharina Houliara, Arnulf Pekrun, et al.
The Medical Journal of Australia|November 4, 2009
Can prior vaccinations against certain infections confer protection against developing melanoma?John M Grange, Bernd Krone, Klaus F Kölmel, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological controlBernd Krone, Klaus F Kölmel, Beate M Henz, et al.
Clinical and Vaccine Immunology : CVI|July 11, 2006
Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndromeRuprecht Schmidt-Ott, Holger Schmidt, Sylvia Feldmann, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMC Neurology|July 20, 2013
Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?Bernd Krone, John M Grange
Inflammopharmacology|May 7, 2011
Paradigms in multiple sclerosis: time for a change, time for a unifying conceptBernd Krone, John M Grange
Autoimmune Diseases|January 4, 2011
Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background?Bernd Krone, John M Grange
Journal of Neurology|March 3, 2009
Is the risk of multiple sclerosis related to the 'biography' of the immune system?Bernd Krone, Frank Oeffner, John M Grange
European Journal of Cancer (Oxford, England : 1990)|June 6, 2009
Immunotherapy for malignant melanoma--tracing Ariadne's thread through the labyrinthJohn M Grange, Bernd Krone, John L Stanford
BMC Cancer|August 17, 2014
The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategiesBernd Krone, Klaus F Kölmel, John M Grange
Scandinavian Journal of Infectious Diseases|January 16, 2004
Impact of conventional chemotherapy on levels of antibodies against vaccine-preventable diseases in children treated for cancerDirk Reinhardt, Katharina Houliara, Arnulf Pekrun, et al.
The Medical Journal of Australia|November 4, 2009
Can prior vaccinations against certain infections confer protection against developing melanoma?John M Grange, Bernd Krone, Klaus F Kölmel, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological controlBernd Krone, Klaus F Kölmel, Beate M Henz, et al.
Clinical and Vaccine Immunology : CVI|July 11, 2006
Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndromeRuprecht Schmidt-Ott, Holger Schmidt, Sylvia Feldmann, et al.
Pageof 2